Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Maly

Showing results (191-200 of 229) with videos related to

Pageof 23
Sort By:
Molecular Cell|April 9, 2019
A Combined Approach Reveals a Regulatory Mechanism Coupling Src's Kinase Activity, Localization, and Phosphotransferase-Independent FunctionsEthan Ahler, Ames C Register, Sujata Chakraborty, et al.
Cell Metabolism|April 6, 2017
Targeting ABL-IRE1α Signaling Spares ER-Stressed Pancreatic β Cells to Reverse Autoimmune DiabetesShuhei Morita, S Armando Villalta, Hannah C Feldman, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2012
Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1Zhongsheng Zhang, Kayode K Ojo, Steven M Johnson, et al.
ACS Infectious Diseases|March 10, 2018
7 H-Pyrrolo[2,3- d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1 H-Pyrazolo[3,4- d]pyrimidin-4-amine-Based InhibitorsRama S R Vidadala, Martin Golkowski, Matthew A Hulverson, et al.
Cell Metabolism|May 4, 2017
Targeting ABL-IRE1α Signaling Spares ER-Stressed Pancreatic β Cells to Reverse Autoimmune DiabetesShuhei Morita, S Armando Villalta, Hannah C Feldman, et al.
The Journal of Infectious Diseases|July 24, 2013
A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosisAlejandro Castellanos-Gonzalez, A Clinton White, Kayode K Ojo, et al.
Plos One|April 1, 2014
Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapyKayode K Ojo, Molly C Reid, Latha Kallur Siddaramaiah, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2017
5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvumWenlin Huang, Ryan Choi, Matthew A Hulverson, et al.
Parasitology|June 14, 2014
The gatekeeper residue and beyond: homologous calcium-dependent protein kinases as drug development targets for veterinarian Apicomplexa parasitesKatelyn R Keyloun, Molly C Reid, Ryan Choi, et al.
Journal of the American Academy of Dermatology|August 23, 2019
Prognostic value of inositol polyphosphate-5-phosphatase expression in recurrent and metastatic cutaneous squamous cell carcinomaConnor J Maly, Helen J L Cumsky, Collin M Costello, et al.
Pageof 23

Showing results (191-200 of 229) with videos related to

Sort By:
Pageof 23
Molecular Cell|April 9, 2019
A Combined Approach Reveals a Regulatory Mechanism Coupling Src's Kinase Activity, Localization, and Phosphotransferase-Independent FunctionsEthan Ahler, Ames C Register, Sujata Chakraborty, et al.
Cell Metabolism|April 6, 2017
Targeting ABL-IRE1α Signaling Spares ER-Stressed Pancreatic β Cells to Reverse Autoimmune DiabetesShuhei Morita, S Armando Villalta, Hannah C Feldman, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2012
Benzoylbenzimidazole-based selective inhibitors targeting Cryptosporidium parvum and Toxoplasma gondii calcium-dependent protein kinase-1Zhongsheng Zhang, Kayode K Ojo, Steven M Johnson, et al.
ACS Infectious Diseases|March 10, 2018
7 H-Pyrrolo[2,3- d]pyrimidin-4-amine-Based Inhibitors of Calcium-Dependent Protein Kinase 1 Have Distinct Inhibitory and Oral Pharmacokinetic Characteristics Compared with 1 H-Pyrazolo[3,4- d]pyrimidin-4-amine-Based InhibitorsRama S R Vidadala, Martin Golkowski, Matthew A Hulverson, et al.
Cell Metabolism|May 4, 2017
Targeting ABL-IRE1α Signaling Spares ER-Stressed Pancreatic β Cells to Reverse Autoimmune DiabetesShuhei Morita, S Armando Villalta, Hannah C Feldman, et al.
The Journal of Infectious Diseases|July 24, 2013
A novel calcium-dependent protein kinase inhibitor as a lead compound for treating cryptosporidiosisAlejandro Castellanos-Gonzalez, A Clinton White, Kayode K Ojo, et al.
Plos One|April 1, 2014
Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapyKayode K Ojo, Molly C Reid, Latha Kallur Siddaramaiah, et al.
Antimicrobial Agents and Chemotherapy|May 24, 2017
5-Aminopyrazole-4-Carboxamide-Based Compounds Prevent the Growth of Cryptosporidium parvumWenlin Huang, Ryan Choi, Matthew A Hulverson, et al.
Parasitology|June 14, 2014
The gatekeeper residue and beyond: homologous calcium-dependent protein kinases as drug development targets for veterinarian Apicomplexa parasitesKatelyn R Keyloun, Molly C Reid, Ryan Choi, et al.
Journal of the American Academy of Dermatology|August 23, 2019
Prognostic value of inositol polyphosphate-5-phosphatase expression in recurrent and metastatic cutaneous squamous cell carcinomaConnor J Maly, Helen J L Cumsky, Collin M Costello, et al.
Pageof 23